Peter C. Minneci, MD :: Nationwide Children's Hospital, Columbus, Ohio
Peter C. Minneci menu

e-newsletters

Sign up for Health e-Hints our FREE customized health informaion parent enewsletter Sign up for Peds Online our Free Medical Professional Enewsletter

stay connected

 

live referral help

Click here to speak with a hospital representative.

Contact Information

Pediatric Surgery
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-3900
FX: (614) 722-3903

Location Information for Patients

Main Campus

Biography

Dr. Minneci graduated from New York University School of Medicine and completed a surgery residency and research fellowship at Massachusetts General Hospital and the National Institutes of Health. He is board certified by the American Board of Surgery in Surgery and Surgical Critical Care and is a member of the American College of Surgeons, Society of Critical Care Medicine, and Alpha Omega Alpha.

View CV »

Gender:

  • Male

Languages Spoken:

  • English

Research Interests

Education and Training

Medical School

  • New York University School of Medicine
    Date Completed: 06/30/1998

Internship

  • Massachuttes General Hospital
    Date Completed: 06/30/2001

Fellowship

  • National Institute of Health
    Date Completed: 06/30/2002

Fellowship

  • National Institute of Health
    Date Completed: 06/30/2005

Residency

  • Massachusetts General Hospital
    Date Completed: 06/30/2007

Fellowship

  • Children's Hospital of Philadelphia
    Date Completed: 06/30/2011

Department:

  • Pediatric Surgery

Section:

  • General Pediatric Surgery

Specialty:

  • Pediatric Surgery
  • Surgery
  • Surgical Critical Care

Date of Appointment at Nationwide Children’s Hospital:

  • 10/31/2011

Publications

  • Peter Minneci. 2011. Biliary Atresia. In Fundamentals.: Springer.
  • Deans KJ, Minneci P, Eichacker PQ, Danner RL, Natanson C. 2010. Walk a mile in whose shoes?.  Anesth Anal. Vol. 111, no. 2. (August): 576-577.
  • Deans KJ, Minneci PC, Danner RL, Eichacker PQ, Natanson C. 2010. Practice misalignments in randomized controlled trials: identification, impact, and potential solutions.  Anesth Anal. Vol. 111, no. 2. (August): 444-450.
  • Deans KJ, Minneci PC, Klein HG, Natanson C.The relevance of practice misalignments to trials in transfusion medicine. Vox Sang. 2010 Jul 1;99(1):16-23. Epub 2010 Mar 21. PubMed ID: 20345517
  • Deans KJ, Minneci PC, Klein HG, Natanson C. 2010. The relevance of practice misalignments to trials in transfusion medicine.  Vox Sang. Vol. 99, no. 1. (July): 16-23.
  • Deans KJ, Minneci PC. 2010. ACP Journal Club. Intensive insulin therapy did not reduce mortality more than conventional therapy in septic shock treated with corticosteroids.  Ann Intern Med. Vol. 152, no. 10. (May): JC5-5.
  • Deans KJ, Minneci PC. 2010. ACP Journal Club. Intensive insulin therapy did not reduce mortality more than conventional therapy in septic shock treated with corticosteroids.  Annals of internal medicine. Vol. 152, no. 10. (May): JC5-5.
  • Barochia AV, Cui X, Vitberg D, Suffredini AF, O'Grady NP, Banks SM, Minneci P, Kern SJ, Danner RL, Natanson C, Eichacker PQ. 2010. Bundled care for septic shock: An analysis of clinical trials.  Crit Care Med. Vol. 38, no. 2. (February): 668-678.
  • Minneci PC, Flake AW. 2010. Biliary Atresia. In Fundamentals of Pediatric Surgery. Edited by Mattei P. New York: Springer.
  • Minneci PC, Deans KJ, Natanson C. 2010. Applying the Results of Randomized Controlled Trials: Caveat Emptor. In Patient Safety and Quality of Care in Intensive Care Medicine. Edited by Chiche JD, Moreno R, Putensen C, Rhodes A. Berlin: MWV Medizinisch Wissenschaftliche.
  • Peter Minneci. 2010. Applying the results of randomized controlled trials: Caveat Emptor. In Patient Safety and Quality of Care in Intensive Care Medicine.: MWV Medizinisch Wissenschaftliche.
  • Minneci PC, Deans KJ, Natanson C. Corticosteroid therapy for severe sepsis and septic shock.JAMA. 2009 Oct 21;302(15):1643; author reply 1644-5. PubMed ID: 19843895
  • Minneci PC, Deans KJ, Natanson C. 2009. Corticosteroid therapy for severe sepsis and septic shock.  JAMA. Vol. 302, no. 15. (October): 1643-1643.
  • Deans KJ, Minneci PC, Chen H, Kern SJ, Logun C, Alsaaty S, Norsworthy KJ, Theel SM, Sennesh JD, Barb JJ, Munson PJ, Danner RL, Solomon MA. 2009. Impact of animal strain on gene expression in a rat model of acute cardiac rejection.  BMC GENOMICS. Vol. 10, no. June: e280.
  • Minneci PC, Deans KJ, Eichacker PQ, Natanson C. 2009. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis.  Clin Microbiol Infect. Vol. 15, no. 4. (April): 308-318.
  • Minneci PC, Deans KJ, Eichacker PQ, Natanson C. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect. 2009 Apr;15(4):308-18. PubMed ID: 19416302
  • Solomon SB, Minneci PC, Deans KJ, Feng J, Eichacker PQ, Banks SM, Danner RL, Natanson C, Solomon MA. 2009. Effects of intra-aortic balloon counterpulsation in a model of septic shock.  Crit Care Med. Vol. 37, no. 1. (January): 7-18.
  • Minneci PC, Deans KJ, Shiva S, Zhi H, Banks SM, Kearns S, Natanson C, Solomon SB, Gladwin MT. 2008. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 295, no. 2. (August): H743-H754.
  • Minneci PC, Deans KJ, Shiva S, Zhi H, Banks SM, Kern S, Natanson C, Solomon SB, Gladwin MT. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H743-54. Epub 2008 Jun 13. PubMed ID: 18552166
  • Minneci PC, Eichacker PQ, Danner RL, Banks SM, Natanson C, Deans KJ. 2008. The importance of usual care control groups for safety monitoring and validity during critical care research.  Intensive Care Med. Vol. 34, no. 5. (May): 942-947.
  • Minneci PC, Deans KJ, Hansen B, Parent C, Romines C, Gonzales DA, Ying SX,. 2007. A canine model of septic shock: balancing animal welfare and scientific relevance.  Am J Physiol Heart Circ Physiol. Vol. 293, no. 4. (October): H2487-H2500.
  • Deans KJ, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, Ciu X, Klein HG, Schechter AN, Banks SM, Eichacker PQ, Natanson C. 2007. Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols.  Crit Care Med. Vol. 35, no. 6. (June): 1509-1516.
  • Minneci PC, Deans KJ, Xizhong C, Banks SM, Natanson C, Eichacker PQ. 2006. Antithrombotic therapies for sepsis: A need for more studies.  Crit Care Med. Vol. 34, no. 2. (February): 538-541.
  • Deans KJ, Minneci PC, Banks SM, Natanson C, Eichacker PQ. 2006. Tidal volumes in acute respiratory distress syndrome - One size does not fit all - Author reply.  Crit Care Med. Vol. 34, no. 1. (January): 264-267.
  • Deans KJ, Minneci PC, Cui X, Banks SM, Natanson C, Eichacker PQ. 2006. The Need to Account for Existing Practice Patterns in Trials of Mechanical Ventilation. In Principles and Practice of Mechanical Ventilation. 2nd ed. Edited by Tobin MJ. New York: McGraw Hill.
  • Minneci PC, Deans KJ, Banks SM, Natanson C, Eichacker PQ. 2006. A Critical Review of Randomized Controlled Trials of Tidal Volume Reduction During ARDS. In Ventilator Induced Lung Injury. Edited by Tobin MJ. New York: Marcel Dekker, Inc.
  • Deans KJ, Minneci PC, Banks SM, Xizhong C, Natanson C, Eichacker PQ. 2006. Mechanical ventilation in ARDS.  Crit Care Med. Vol. 34, no. 1. (January): 263-267.
  • Deans KJ, Minneci PC, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB. 2005. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.  J Clin Invest. Vol. 115, no. 12. (December): 3409-3417.
  • Minneci PC, Deans KJ, Banks SM. 2005. Low-dose corticosteroids were superior to high-dose, short-term therapy for improving survival in sepsis.  Ann Intern Med. Vol. 143, no. 9. (November): e680.
  • Deans KJ, Minneci PC, Xizhong C, Banks SM, Natanson C, Eichacker PQ. 2005. Mechanical ventilation in ARDS: One size does not fit all.  Crit Care Med. Vol. 33, no. 5. (May): 1141-1143.
  • Deans KJ, Haley M, Natanson C, Eichacker PQ, Minneci PC. 2005. Novel therapies for sepsis: A review.  J Trauma. Vol. 58, no. 4. (April): 867-874.
  • Peter Minneci. 2005. Factors influencing the efficacy of mediator-specific anti-inflammatory, glucocorticoid and anti-coagulant therapies for sepsis. In Drug Discovery Handbook.: Wiley Interscience.
  • Deans KJ, Natanson C, Minneci PC. 2005. The dose-dependent effects of steroid therapy on survival in sepsis: A meta-analysis.  Contagion. Vol. 2, no. 1. (January): 14-21.
  • Minneci PC, Deans KJ, Haley M, Xizhong C, Natanson C, Eichacker PQ. 2005. Factors Influencing the Efficacy of Mediator-Specific Anti-Inflammatory, Glucocorticoid and Anti-Coagulant Therapies for Sepsis. In Drug Discovery Handbook. Edited by Gad SC. Hoboken: Wiley Interscience.
  • Deans KJ, Minneci PC, Eichacker PQ, Natanson C. 2004. Defining the standard of care in randomized controlled trials of titrated therapies.  Curr Opin Crit Care. Vol. 10, no. 6. (December): 579-582.
  • Deans KJ, Minneci PC, Banks SM, Natanson C, Eichacker PQ. 2004. Substantiating the concerns about recombinant human activated protein C use in sepsis.  Crit Care Med. Vol. 32, no. 12. (December): 2542-2543.
  • Minneci PC, Deans KJ, Banks SM, Costello R, Csako G, Eichacker PQ, Danner RL, Natanson C, Solomon SB. 2004. Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock.  Am J Physiol Heart Circ Physiol. Vol. 287, no. 6. (December): H2545-H2554.
  • Deans KJ, Natanson C, Minneci PC. 2004. Dose effects of steroids on survival in sepsis - Response.  Ann Int Med. Vol. 141, no. 11. (December): e892.
  • Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. 2004. Corticosteroids for septic shock.  Ann Intern Med. Vol. 141, no. 9. (November): 742-743.
  • Deans KJ, Minneci PC, Eichacker PQ, Natanson C. 2004. The efficacy of rhAPC depends on severity of illness.  Crit Care Med. Vol. 32, no. 11. (November): 2347-2347.
  • Haley M, Xizhong C, Minneci PC, Deans KJ, Natanson C, Eichacker PQ. 2004. Recombinant human activated protein C in sepsis: Previous concerns and current usage.  Am J Med Sci. Vol. 328, no. 4. (October): 215-219.
  • Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. 2004. Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose.  Ann Intern Med. Vol. 141, no. 1. (July): 47-56.
  • Minneci PC, Deans KJ, Kim P, Mathisen DJ. 2004. Foramen of Morgagni hernia: Changes in diagnosis and treatment.  Ann Thor Surg. Vol. 77, no. 6. (June): 1956-1959.
  • Haley M, Cui X, Minneci PC, Deans KJ, Natanson C, Eichacker PQ. 2004. Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness.  Curr Opin Infect Dis. Vol. 17, no. 3. (June): 205-211.
  • Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. 2004. Should we continue to target the platelet-activating factor pathway in septic patients?.  Crit Care Med. Vol. 32, no. 2. (February): 585-588.
  • Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. 2004. Is it appropriate to withhold beneficial therapy in critical illness? Response.  BMJ. Vol. 1, no. January: 480-484.
  • Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. 2004. Re: Corticosteroids for sepsis and septic shock - Credible evidence………..or not? Response.  BMJ. Vol. 329, no. January: 480-484.
  • Haley M, Xizhong C, Minneci PC, Deans KJ, Natanson C, Eichacker PQ. 2004. Recombinant human activated protein C: Assessing its clinical use.  Therapy. Vol. 1, no. January: 123-129.
  • Minneci PC, Mathisen DJ. 2003. Minor challenges: Modified diverticulectomy and myotomy for recurrent Zenker diverticulum.  J Thorac Cardiovasc Surg. Vol. 125, no. 4. (April): 969-971.
  • Deans K, Minneci P, Eichacker PQ, Natanson C. 2003. Anti-Inflammatory Agents: A Double Edged Sword in out Arsenal Against Septic Shock. In Shock and Multiorgan Failure. Edited by Net A. Iberica: Spriger-Verlag.
  • Minneci P, Deans K, Natanson C, Eichacker PQ. 2003. Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.  Eur J Clin Microbiol Infect Dis. Vol. 22, no. 1. (January): 1-9.
  • Peter Minneci. 2003. Anti-inflammatory agents: A double edged sword in our arsenal against septic shock. In Shock and Multiorgan Failure.: Springer-Verlag.
  • Schwartz JD, Shamamian P, Schwartz DS, Grossi EA, Jacobs CE, Steiner F, Minneci PC, Baumann FG, Colvin SB, Galloway AC. 1998. Cardiopulmonary bypass primes polymorphonuclear leukocytes.  J Surg Res. Vol. 75, no. 2. (March): 177-182.
  • Deans KJ, Minneci P, Eichacker PQ, Danner RL, Natanson C. Walk a mile in whose shoes? Anesth Analg. 2010 Aug;111(2):576-7; author reply 577. PubMed ID: 20664096
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000